World Coronavirus Dispatch: US agency questions AstraZeneca's outdated data

UK faces 'Covid decade' due to damage done by pandemic, US health body questions robustness of AstraZeneca's data and other pandemic-related news across the globe

Topics
Coronavirus | Coronavirus Vaccine | Coronavirus Tests

Akash Podishetty  |  Hyderabad 

Brazil, Saudi Arabia and Morocco 'told of delay in Covid jabs from India'

India's Serum Institute of India (SII) has told Brazil, Saudi Arabia and Morocco that further supplies of the Oxford-AstraZeneca Covid-19 vaccine will be delayed because of surging demand at home and work on capacity expansion, according to a report in the Guardian. India, the world’s biggest vaccine maker, is being criticised domestically for donating or selling more doses than it administers at home, despite reporting the most number of infections after the US and Brazil. Read here

Let's look at the global statistics

Global infections: 123,691,979

Global deaths: 2,723,353

Nations with most cases: US (29,869,518), Brazil (12,047,526), India (11,686,796), Russia (4,416,226), United Kingdom (4,358,910).


UK faces 'Covid decade' due to damage done by pandemic

Britain faces a “Covid decade” of social and cultural upheaval marked by growing inequality and deepening economic deprivation, according to a British Academy report. Major changes to the way society is run in the wake of the pandemic are needed to mitigate the impact of the “long shadow” cast by the virus, including declining public trust and an explosion in mental illness. The British Academy warned that failure to understand the scale of the challenge ahead and deliver changes would result in a rapid slide towards poorer societal health, more extreme patterns of inequality and fragmenting national unity. Read here

US health body questions robustness of AstraZeneca's data

AstraZeneca may have provided an incomplete view of efficacy data on its Covid-19 vaccine from a large-scale US trial, the US National Institute of Allergy and Infectious Diseases says, in a fresh setback for the shot. The drugmaker said a day earlier that its vaccine developed with Oxford University was 79 per cent effective in preventing symptomatic illness in a large trial. "There are concerns that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data," the US agency said. Read here

Germany introduces a strict, five-day lockdown over Easter

Angela Merkel, Chancellor of Germany, announced a five-day lockdown over Easter and the extension of existing restrictions until mid-April in an effort to break a spike in cases. She warned that the country is facing a significantly more deadly wave of the Starting April 1, Germany will effectively shut down for an extended Easter break, with private meetings limited to only two groups of up to five adults and all stores ordered shuttered, with only supermarkets allowed to open on the Saturday. Churches are asked to hold services online, and people are being asked to stay home and not travel. Read here

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Tue, March 23 2021. 14:08 IST
RECOMMENDED FOR YOU